Neuroendocrine Tumor Clinical Trials

Find Neuroendocrine Tumor Clinical Trials Near You

Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm: A Prospective Single-Centre Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Study objectives: Primary objective: 1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm. Secondary objectives: To evaluate: 1. En bloc resection rate 2. Immediate and delayed adverse events 3. Procedure time 4. Histologic quality of resection (deep and lateral margins) 5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

⁃ Patient-level

• Age ≥18 years

• Fit for endoscopic therapy and sedation

• Written informed consent

Locations
Other Locations
India
Asian Institute of Gastroenterology/AIG Hospitals
RECRUITING
Hyderabad
Contact Information
Primary
Rajesh Mr Goud, M.Pharmacy
rajeshgoud761@gmail.com
04023378888
Backup
Shashavali Dr Maniyar, MD
shashimaniyar@gmail.com
04023378888
Time Frame
Start Date: 2026-07-17
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 60
Treatments
Other: Type I Gastric Neuro Endocrine tumour
Lesion should be less than 10mm size
Related Therapeutic Areas
Sponsors
Leads: Asian Institute of Gastroenterology, India

This content was sourced from clinicaltrials.gov